RetaMaps

Retatrutide in Live Oak, TX: status & local weight-loss providers

Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.

Phase 3 complete · Not FDA-approvedRetatrutide: Phase 3 complete · FDA submission planned Q1 2027 · Not available outside trials / expanded access. Tracker
3
tracked providers
2
have 100+ Google reviews

Pins reflect street addresses where available; others are approximate (ZIP-level).

Get retatrutide updates for Live Oak

Nearby markets

Universal City (2)Schertz (1)Selma (1)San Antonio (45)Bulverde (1)New Braunfels (3)All of Texas →

Learn about retatrutide

FDA approval trackerWhat is retatrutide?When will retatrutide be available?

Frequently asked questions

Can I get retatrutide in Live Oak today?

No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Live Oak or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.

What do the providers listed for Live Oak actually offer?

They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.

Does being listed mean a Live Oak provider will prescribe retatrutide?

No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.

How do I hear when availability changes near Live Oak?

Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.